Passage Bio, Inc.
PASG
$8.49
$0.465.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.81% | -25.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.25% | -25.24% | |||
| Operating Income | 16.25% | 25.24% | |||
| Income Before Tax | 17.43% | 39.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.43% | 39.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.43% | 39.08% | |||
| EBIT | 16.25% | 25.24% | |||
| EBITDA | 16.64% | 25.37% | |||
| EPS Basic | 17.69% | 40.30% | |||
| Normalized Basic EPS | 17.69% | 27.97% | |||
| EPS Diluted | 17.69% | 40.30% | |||
| Normalized Diluted EPS | 17.69% | 27.97% | |||
| Average Basic Shares Outstanding | 0.31% | 2.04% | |||
| Average Diluted Shares Outstanding | 0.31% | 2.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||